What is Theravance Biopharma's other noncash income (expense)?

Theravance Biopharma (TBPH) reported other noncash income (expense) of -$42K in Q1 2026.

How has Theravance Biopharma's other noncash income (expense) changed year-over-year?

Theravance Biopharma's other noncash income (expense) decreased by 207.7% year-over-year, from $39K to -$42K.

What does other noncash income (expense) mean?

This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.

Theravance Biopharma TBPH Other Noncash Income (Expense)

Other Noncash Income (Expense) at other companies

Aurinia PharmaceuticalsAUPH

-$581K+75.0%

Ultragenyx PharmaceuticalRARE

-$1M-200%

OrganonOGN

-$12M+40.0%

Mirum Pharmaceuticals, Inc.MIRM

$278K-21.9%

United TherapeuticsUTHR

——

BridgeBio PharmaBBIO

——

Other financials

Income statement

See full

Revenue$17.7M+15.0%

Operating income-$9.5M+34.3%

Net income-$4.9M+63.7%

EPS (diluted)-$0.10+63.0%

Balance sheet

See full

Cash & equivalents$288.1M+160%

Total debt$40.5M-15.9%

Total equity$290.6M+75.1%

Total assets$472.3M+37.5%

Cash flow

See full

Operating cash flow$73.3M+70.3%

CapEx$8.0K-95.8%

Free cash flow$59.6M+5,560%

Valuation

See full

Market cap$896.51M+68.7%

Enterprise value$648.91M+38.3%

P/E7.8×—

P/S8.2×0.0×

Profitability

See full

Gross margin60.8%—

Operating margin1.2%+0.6pp

Net margin104.3%+71.4pp

FCF margin221.9%+206pp

Returns & leverage

See full

Return on equity50.2%+36.2pp

Debt / equity0.1×-0.2×

Current ratio13.1×+8.4×

Where this comes from

Reported directly by Theravance Biopharma in its filing.

Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.

The official record: Theravance Biopharma’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Theravance Biopharma's other noncash income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Theravance Biopharma's other noncash income (expense)?: Theravance Biopharma (TBPH) reported other noncash income (expense) of -$42K in Q1 2026.
How has Theravance Biopharma's other noncash income (expense) changed year-over-year?: Theravance Biopharma's other noncash income (expense) decreased by 207.7% year-over-year, from $39K to -$42K.
What does other noncash income (expense) mean?: This captures miscellaneous non-cash adjustments to net income that do not fit into standard categories like depreciation or stock-based compensation. It includes items such as changes in fair value of certain liabilities or non-cash impairment charges.